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ABSTRACT 
Systemic lupus erythematosus and rheumatoid arthritis 
in humans are characterized by circulating autoantibodies and 
immune complex deposition in various organs causing tissue 
damage and disease. Atleast in vitro, some of the antibodies 
involved in immune complex formation react with self 
antigens, including nucleic acids and other nuclear antigens, 
IgG from an SLE patient showing high titer anti-DNA 
antibody activity was isolated. Attempts were made to 
precisely define the antibody recognition sites on DNA 
polymer by the isolated IgG. On the basis of competition 
experiments, it has been observed that atleast two classes of 
anti-DNA antibody in SLE IgG exist. The major class being 
reactive with deoxyribose-phosphate backbone or secondary 
structure of DNA. The other class of antibody was found to 
recognize some bases. However, the base specific antibodies 
were found to be reactive mainly with pyrimidines. The order 
of reactivity of SLE IgG with various natural as well as 
synthetic DNA analogues was: 
poly (dG.dC>a> poly (dA.dDg. > ssDNA > nDNA > RNA 
The inhibitory effect of poly (dC) and poly (df) was 
well pronounced on anti-DNA antibody activity of SLE IgG. 
Almost no inhibition was achieved with poly (dA) and poly 
(dG). The data presented here suggest that antigenicity of 
DNA lie mainly in the sugar-phosphate backbone of DNA and at 
carbon 2 (C-2) and oxygen S (0-2) of pyrimidine. 
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I INTRODUCTION 
The immune system has tremendous diversity and the 
repertoire of specificities expressed by the B and T cell 
populations are bound to include many which are directed to 
self components. The complicated mechanisms which the body 
must establish to distinguish between self and nonself 
determinants (Bicker,1986) so as to avoid the embarassment of 
autoreactivity. However, in the nature of things, all 
mechanisms have a risk of breakdown and self recognition 
mechanisms are no exception. 
Aetiology of Autoimmune Diseases 
It is generally accepted that self-reactive 
lymphocytes exist in the body. There occurs a situation in 
which both self-reactive lymphocytes and autoantigens can 
make contact in the normal individual and therefore there 
must be controlling mechanisms which operate in normal 
cicumstances to inhibit the triggering of the autoimmune 
reaction. It seems most likely that suppressor cells are 
important in the containment of this autoreactivity. It has 
been postulated that defects in perhaps more than one type of 
T-suppressor may be important for the development of 
autoimmune response. Studies on the clinically unaffected 
relatives of patients with SLE share with the patients 
themselves a defect in the generation of non-specific T-
suppressors, suggesting first that defect is not a 
consequence of the disease, and secondly that it is unable by 
itself to cause SLE. 
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Some cell surface receptor molecules might be 
immunologically " silent" because the cell membrane does not 
express MHC class II molecules. It was argued that since the 
unresponsiveness of the final effector T and B cells could be 
consequence of suppression or tolerization of autoantigen 
specific T-helper cells (inducer r cells) any circumstances 
leading to the circumvention of these tolerant T cells would 
lead directly to the triggering of effector lymphocytes. A 
novel idea is that the idiotypic network would be involved 
through triggering of a self reactive T or B cells carrying a 
public idiotype cross-reacting with the idiotype on an 
antibody stimulated by microbial agents or with a structure 
on microbe itself. Even in this case, it seems unlikely that 
the autoimmune response would be maintained unless there was 
some defect in the anti-idiotypic T-suppressor cell and this 
emphasize the considerable importance of multiple factors in 
the establishment of prolonged autoimmunity (Cunningham et 
al, 1975; Marchalonis and Cohen,1980; Lechman and 
Peters,1982; Davies et al,1983; Sites et al,1984; Yamamura 
and Tada,1984). 
Techniques for Detecting Autoantibodies 
Different techniques have been used to detect 
antibodies to dsDNA including precipitin reactions in gel but 
the methods like Farr assay (Wold et al,196S), the 
immunofluore- scence technique (IFT) with crithidia luciliae 
(Aarden et al, 1975) and ensymelinked immunosorbent assay 
(ELISA) (Zouli and Stollar,1986) has improved the sensitivity 
of the assay. Since the antibodies to dsDNA vary in class, 
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Table 1 
Physical and Chemical Properties of Immunoglobulin G** 
Current designation IgG 
Older names Y-Globulin, 7S V^lo^"! i" 
Molecular weight 150,000 
SaojW value 6.6 
Electrophoretic mobility t 
Carbohydrate content S.5"/. to 4.07. 
Resistance to -SH reagents High 
Concentration (mg/dl serum) 1275+500 
Amount of serum immunoglobulins 75/i to 857. 
Half life (days) 25 to 35 
Rate of synthesis 28 
(mg/kg body weight/day) 
Light chain types |<0V ^ 
Heavy chain class Y 
General formula "'^iKl^ ^ Z ^2-
Light chain allotypes Km 
Heavy chain subclasses V Yi YJ "^  
Heavy chain allotypes Gm 
Stable at 56<^ C to 60<=C Yes 
#•«• Source Barrett (1983) 
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specificity, DNA precipitating capacity and avidity (Gershwin 
and Steinberg, 1974; Steward et al,19/4|! Winfield et al,1977i; 
Leon et al,1977; Sontheimer and Gi11iam,1978; Papalian et 
al,19S0; Ebling and Hahn,1980; Phillips et ai,1987; Costello 
and Green,1988), it is not surprising that different 
techniques may give rise to different results on the same 
serum, 
Polyspecificily as a Mechanism for Autoantibody Production 
The potential role of DNA and other self antigens as 
immunogens has been called into question by studies on the 
specificity of monoclonal anti-DNA antibodies. These 
antibodies have been obtained from both human and murine 
sources by the hybridoma technique of somatic cell fusion. 
Since the hybridoma derived antibodies are homogeneous 
product, it is possible to analyze their specificity in terms 
of their ability to bind to DNA as well as other antigens, 
both self and foreign. An important finding to emerge from 
this analysis is that some anti-DNA antibodies are 
polyspecific and bind antigens chemically distinct from DNA. 
These include RNA, nuclear proteins such as histones and Sm, 
cell surface antigens, cytoskeletal proteins, phospholipids, 
IgG, and bacterial products (Lafer,1981; Rubin,1984; 
Pisetsky,19a4; Carrol1,1985; Pisetsky,1985). This broad 
pattern of reactivity can be explained by the interaction of 
these antibodies with conformational determinants or charge 
array that are not strictly dependent on certain chemical 
moities for their representation. In this regard, anti-DNA 
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antibodies are conformation or structure specific. While the 
basis of these interactions is uncertain polyspecificity 
nevertheless has important implications for mechanism of auto 
antibody produciton. Certainly, the ability of one antibody 
to different self antigens reduces the serological complexity 
of SLE. It is at least theoretically possible for one 
antibody to cause anti-DNA, anti-histone and rheumatoid 
factor activities. Polyspecificity also provides novel 
pathogenic mechanisms, allowing anti-DNA to form immune 
complexes with non-DNA antigens or mediate disease by cell 
cytotoxicity as well as immune complex formation. 
The phenomenon of polyspecificity has implications 
for mechanisms of autoantibody induction. It is possible that 
any of the cross reactive antigens bound by anti-DNA 
antibodies serve as immunogenic triggers. Thus, anti-DNA 
antibodies could arise from stimulation by another self 
antigen, as has been demonstrated for the response to 
immunisation with cardiolipin <Rauch et al,19S4). It is even 
possible that foreign antigens such as bacteria,induce anti-
DNA antibodies suggesting that SLE results from aberrant 
control of antibody production to an exogenous antigen rather 
a unique responsiveness or loss of self tolerence to an 
endogenous antigen. 
It is important to assess the relationship between 
hybridoma derived anti-DNA antibodies and those expressed in 
SLE while evaluating the significance of polyspecificity. 
Because of the feature of the fusion process and selection 
bias introduced by screening, it is possible that the 
monoclonal antibodies represent a distinct population of 
anti-DNA specificities. It has been shown that most of 
monoclonal antibodies show preferance for asDNA and there is 
uncertainty as to number which would be capable of fixing 
complement or binding dsDNA in a Farr type assay. 
Furthermore, it is now clear that even normal individuals 
contain a substantial proportion of antibodies that ^re 
broadly reactive, binding DNA as well as other antigens 
(Pisetsky,1982; Dighiero,1983). The frequency of these 
antibodies suggests that they are infact essential components 
of the normal B cell repertoire. Thus, in sera of SLE 
patients with both anti-DNA and anti-phospholipid antibodies, 
it has been shown that these antibodies are infact two 
seperate populations that are seperate immunochemically 
(Harris,1985). 
Antigenic Structure of DNA 
Native DNA, the genetic material of most of the 
eucaryotes and procaryotes, is a poor immunogen. Normal 
animals have a remarkable tolerance to native DNA and are 
only capable of making antibodies to ssDNA when complexed to 
methylated bovine serum albumin (MBSA) and presented in 
Freunds' adjuvant (Plescia, 1964). 
DNA, which is known to exist in many conformational 
state can present several kinds of antigenic sites for 
correspondingly heterogeneous SLE sera. Purine or pyrimidine 
bases, or base sequences upto a length of five or six, serve 
as determinants for SLE antibodies that react only with 
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denatured DNA (StoUar, 1973). In native helical DNA the 
bases are inaccessibly directed inward, they are exposed to 
antibody only in denatured DNA. Therefore, base specific 
antibodies don't bind native DNA and their ability to react 
with denatured DNA is not inhibited by native DNA 
A second type of antibody in SLE serum reacts only 
with native DNA, probably with deoKyribose - phosphate 
backbone. These antibodies may also recognise helical 
regions in denatured DNA. To distinguish this type from the 
base specific antibodies, it is important to be sure that 
fully base-paired helical DNA is used as a test antigen. To 
ensure fully helical structure, closed circular bacteriophage 
DNA (Aarden et al ., 1975),synthetic poly (dA.dT)poly(dA.dT) 
(Steinman et a1,1976) or intracellular circular DNA (Aarden 
et al,1975) have been used as test antigen. The extent of 
native structure of the soluble DNA preparations can be 
tested further by measurement of the induced fluorescence of 
ethidium bromide in the presence of DNA at neutral and 
alkaline pH (Davis et al,1978; Ali and Ali, 1984) other 
subpopulations of anti-DNA antibodies may also occur. 1 liey 
may recognize the backbone of one strand and may be able to 
react with both native and denatured DNA. Some antibodies can 
be fractionally adsorbed with synthetic and single-stranded 
homopolydeoxyribonucleotides such as poly(dT) or poly(dC) 
(Koffler et al,1971). 
The size of the DNA used as test antigen has got a 
strong influence on some assays (Ali et al,1985). A single 
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antibody combining site is large enough to encompass both 
backbones of native DNA over an extent of three base 
pair5(or,in the case of denatured determinant, a sequence of 
five or six nucleotides) (Stollar,1973,1975). When helical 
fragments of native DNA were tested in a competitive binding 
assay, pieces of 40-50 base paired long nucleotide were 
required for significant binding by several SLE sera 
(Papalian et al,1980). This may reflect a minimal size 
requirement for the maintenance of a particular stable confor 
mation when bivalent binding become possible. Larger 
fragments were still more efficient, and the use of very high 
molecular weight DNA is required for optimal sensitivity of 
anti-DNA assay (Geisert et al,1975; Aarden et al,1976). Anti-
bodies to A helical forms such as dsRNA and DNA-RNA hybrid 
are found in majority of SLE patients (Schur and Monroe,1969; 
Steinberg et al,1969; Hirousi,19S0). Autoantibodies against 
ssRNA and double stranded synthetic polymers like poly IsC, 
poly A:U (Eilat et al,197S), synthetic ssRNA like poly A,poly 
C (Koffler et al,1971|i PiUarisetty et al,1975) tRNA (Eilat 
et al,1976) and ribosomal RNA (Lamon and Bennet,1970) have 
been well established. RNA antibodies show marked specificity 
for RNA and don't show any cross reactivity with native DNA. 
(Stollar,1970). There are reports for antibodies to histones 
in 95 percent of patients with procainamide induced lupus 
erythematosus (Fritzler and Tan , 1978; Gohill and Fritzler, 
1987) 30 percent of patients with idiopathic SLE (Kunkel et 
al., 1960; Tan et al., 1976) and 35 percent of patients wxth 
rheumatoid arthritis (Aitcheson et al, 1980). These 
antibodies were found to react with H1, HSA, H2B, H3 and H4 
histone subpopulations (ReKvig and Hannestad, 1979). It has 
been reported that the majority of drug induced lups patients 
had antibodies directed against the H2A-H2B histone complex. 
(Tan and Portanova,1981), 
Recent studies have explored the significance of 
antibodies to nuclear nonhistone (acidic) antigen Stn (Tan and 
Kunkel, 1966; Suzuki et al, 1987) RNP (Sharp et al, 1972; 
Ishaq and Ali, 1987), Ro or SS-A (Clark et al, 1969), La or 
SS~B (Alspaugh and Tan, 1975; Alspaugh et al, 1976; Akizuki 
et al, 1977), and have demonstrated their diagnostic 
specificity and associsation with certain clinical features 
in these diseases. 
Avidity and Disease Exacerbation 
The avidity of autoantibodies to dsDNA is likely to 
be related with the chronic stage of the disease. However, 
avidity studies have led to the conflicting rewsults (Steward 
et al, 1975; Tron and Leon 1977; Bach et al, 1977; Winfield 
et al, 1977; Griffiths et al, 1978; Aarden et al, 1979). 
Sera of the patients afflicted with SLE contained atleast two 
distinct populations of antibodies to dsDNA. One population 
was of higher avidity and dissociated slowly in the presence 
of excess DNA or high salt. Another population showed low 
avidity toward ds DNA and dissociated more rapidly under the 
same condition. The results of double lebel dissociation 
kinetic studies provided independent evidence supporting this 
hypothesis (Riley et al, 1980). The heterogeneity of anti-
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DNA antibodies in SLt" sera and the recognition of the 
secondary strructure of antigen for specific binding was 
establishned using dsDNA fragments of varying sizes (20 to 
1200 bp). Competitive assays with mononucleotides, 
oligonucleotides, homopolymers and RNA-DNA hybrid indicated 
that two strands of polydeoxyribonucleotide were required for 
optimal reaction with these SLE antibodies (Ethel and Gunnel, 
1980; Papalian et al, 1980; Stollar and Papalian, 1980). 
Pathogenic Role of Immune Complexes in SLE 
DNA- anti~DNA immune compleKes play an important role 
in the pathogenesis of SLE (Winfield, 1975; Adu, 1981; Emlen 
and Burdick,1988). Numerous studies have demonstrated DNA-
anti~"DNA immune complexes in the circulation of patients with 
SLE (Adu, 1981; Bruneau, 1979; Daha et al, 1988). DNA from 
immune complex in SLE patients have also been isolated (Sano 
and Morimoto,1981; Morimoto et al,1982). The earlier 
studies showed that when some DNA- anti-DNA immune complexes 
are digested with excess DNase in vitro, a portion of the DNA 
remains bound to IgG that is protected from digestion with 
DNase (Emlen, 1984). However, when immune complexes are 
formed in antigen excess, so that only one IgG is bound per 
molecule (Aarden, 1976), the resultsant DNase resistant DNA 
feagment is 35 to 40 base pair in length. Base pairs smaller 
than 35 to 45 were not effective ligand which is necessary in 
order to maintain a stable conformation. Because DNase is 
present in circulation (Love, 1979) the presence of small DNA 
in circulating immune complex is well established (Sano, 
1981: Morimoto, 1982). The protected DNA fragment 
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represents the DNA that spans the Fab arms of a single IgG 
molecule and is rendered inaccessible to DNase by virtue of 
high-avidity monogamous bivalent binding of IgG to DNA 
(Emlen, 19845 Papalian, 1980). 
The rate of dissociation of DNA- anti-DNA complexes 
in the presence of excess unlabeled DNA was studied as a 
function of temperature and DNA conformation. At low 
temperatures dissociation of complexes of antibody and ssDNA 
or dsDNA was slow and did not reach equilibrium. At SJ^ 'C the 
rates for dissociation of ss DNA/antibody complexes were 
generally rapid, dissociation being completed within one 
hour, dsDNA/antibody complexes on the other hand were much 
more stable than those formed with ssDNA (Winfield, 1979). 
Either excess unlabeled DNA or high salt concentration were 
employed to induce complex dissociation. 
Objectives of the Present Study 
The study of anti-DNA antibody specificity and 
characteristics is significant because of their diversity 
with respect to antigen binding. Well defined and 
characterised antibodies could be utilised for maintaining 
the change in DNA conformation during the transfer of genetic 
information. This is an addition to well documented 
diagnostic significance of anti-DNA antibodies. Their level 
could well be correlated with disease activity. Moreover, 
DNA-antibody interaction could serve as a non-destructive 
model for the study of DNA-protein interaction so very vital 
for gene function and regulation. 
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The present study was thus planned to systematically 
characterise anti~DNA antibody purified from serum of a 
patient with SLE. Commercially available calf thymus DNA was 
purified to get rid of contaminmation by protein, RNA and 
simple stranded regions. Both native and heat denatured DNA 
was used as antigen besides synthetic DNA analogues. 
Emphasis has been laid on competition ELISA wherein various 
nucleic acid polymers were used as inhibitors for nDNA-
antibody interaction for the evaluation of binding data. 
Direct binding assay on solid surface coated with altogether 
different polymers generate data which is difficult to 
evaluate for a comparative study. 
13 
II EXPbRIMENTAL 
A. Materials 
1. Chemicals 
Calf thymus native DNA,bovine serum albumin,xylene 
cyanole FF',Coomma5sie Brilliant Blue R250, polydeoxyadenyalate 
(poly dA) , polydeoxythymidylate (poly dT) ,a>3arose, ethidium 
bromide,anti-Human and anti-Rabbit IgG alkaline phosphatase 
conjugate were purchased from Sigma chemical company, U.S.A. 
Polystyrene flat bottom plates having 96 wells (7mm in diam-
eter) were obtained from Dynatech U.S.A. Freunds' complete 
and incomplete adjuvants were purchased from Difco chemical 
company U.S.A. Acrylamide,bis-acrylamide,N-N-N'-N' tetraethy-
Imethylenediamine,ammonium persulphate, hydroKylapatite and 
Tween-20 was obtained from Bio-Rad Laboratories U.S.A. Sepha-
rose CL4B,agarose NA,polydeoxycytidylate (poly dC),polydeoxy-
guanilate (poly dG),alternate copolymers poly (dA.dT) poly 
(dA.dT) and poly (dG.dC) poly ( dG. dC ) ,Sephade!< G-EOO,Fi col 1-
400 and DEAE Sephacel were obtained from Pharmacia Fine 
Chemicals Sweden. A colorigenic substrate p-nitrophenylphosp-
phate was obtained from C.S.l.R. center for Biochemicals 
Delhi. All other chemicals used were of highest grade availa-
ble . 
2. Equipment 
Bauch and Lomb Spectronic 20, Shimadzu UV 240 
spectrophotometer,Dynatech ELISA Microplate Reader 
MR600,Pharmacia GNA 100,ELIC0 pH meter model L1-10T,EL1C0 
conductivity bridge and ultraviolet lamp were the major 
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equipments used in the present study-
3. Sera 
Normal human sera were collected from healthy 
laboratory personnel. Sera of patients with systemic lupus 
erythematosus (SLE) and other autoimmune diseases were 
obtained from outdoor and indoor patients of the Department 
of Medicine J. N-Medical col lege,A.M.U.,A1igarh. Patients 
with this disease had features meeting atleast four revised 
criteria of the American Rheumatism Association (ARA) for 
this disease (Tan et al,19S2) Blood from rabbits was 
collected by cardiac puncture and sera was seperated four 
hours after keeping the blood at room tempera-ture. All sera 
were decomplemented by heating at 56*^ C for thirty minutes and 
kept small aliquoted at -20*^ C until use with 0.1"/. sodium 
azide as preservative. 
B. Methods 
1. Determination of Protein Concentration 
Protein was estimated by the method of Lowry et al. 
(1951) as described below 
a. Folin-Ciocalteu Reagent 
The reagent was purchased from C.S.l.R. center for 
Biochemicals,Delhi. It was diluted 1:4 with distilled water 
before use. 
b. Alkaline Copper Reagent 
The constituents of the alkaline copper reagent were 
1. Two percent sodium carbonate in 0.1M sodium hydroxide, 
ii. 0.5 percent copper sulphate in 1.0 percent sodium 
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potassium tartrate. 
The working reagent was prepared fresh by mixing 
components i and 11 In the ratio of 50:1 
c. Procedure 
To one ml. of protein samples were added five ml. of 
alkaline copper reagent. After mixing the contents 
thoroughly, the tubes were left for ten minutes at room 
temperature. One ml of FolIn-Ciocalteu reagent was added and 
after 30 min the absorbance was monitored at 660 nm. 
Concentration of unknown samples were computed from a 
standard plot drawn, using bovine serum albumin (Fig.l). 
Z. Deoxyribonucleic Acid (DNA) Purification 
Commercially purchased calf thymus DNA was 
deproteinated by repeated extraction with chloroform-
isoamylalcohol (24!l). DNA solution (2 mg/ml) in 0.1 SSC 
buffer (0.0ISM Na-citrate, 0.15M sodium chloride, pH 7.3) 
was mixed with equal volume of chloroform-isoamylalchohol 
(24:1) in a stoppered measuring cylinder. The cylinder was 
sealed and the contents were mixed end to end gently for one 
hour. The DNA present in acqueous phase was separated from 
the organic layer by low speed centrifugation. The 
extraction process was repeated once. Tht; DNA was 
precipitated with two volumes of cold 957. ethanol and 
collected on a glass rod. It was dried by pressing against 
the wall of the container. The sample was once rinsed with 
ethanol to remove any traces of water. The DNA thus obtained 
was dissolved in 0.1 SSC buffer and treated with RNase A (50 
JB 
0.50 
^0 80 120 
[BSA] jjg 
160 200 
Fig.1. Standard plot for co]orimetric 
estimation of protein 
jag/ml) for thirty minutes at Sl'^^C to digest RNA in case 
present. The digested DNA was precipitated and dried as 
earlier and dissolved in 30 mM acetate buffer, pH 5.0 
containing 30 mM ZnC12. The above preparation of DMA might 
contain some single strand regions- The sample was digested 
with single strand specific enzyme, nuclease SI (230 units/mg 
DNA) at 37<^ C for 30 min. The reaction was terminated by 
adding 1/10 volume of 0.2 M EDTA, pH 8.0. The purified DNA 
was extracted twice with chloroform-isoamylalcohol and 
precipitated with cold 957, ethanol. The precipitate was 
dried and dissolved in PBS (10 mM Na-phosphate, 150 mM Nacl) 
pH 7.4 
3. Determination of Deoxyribonucleic acid (DNA) Concentration 
DNA was estimated colorimetrically according to 
Burton (1956) using diphenylamine reagent. 
a. Reagent preparation 
To 750 mg of recrystal1ised diphenylamine was added 
50 ml of glacial acetic acid and 0.75 ml of concentrated 
sulphuric acid. The reagent was prepared fresh before use. 
b. Procedure 
One ml of 1 N perchloric acid was added to 1.0 ml of 
DNA sample. The tubes were incubarted for 15 minutes in a 
water bath maintained at 70°C. Hundred )JL of 54.3 mM 
acetaldehyde was added followed by 2.0 ml of di pheny lamiriy 
reagent. The tubes were mixed and allowed to stand at room 
temperature for 16-20 hours. Absorbance was recorded at 600 
nm. The DNA concentration in unknown sample was determined 
from the standard plot constructed using purified calf thymus 
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native DNA (Fig.S). 
4. Isolation of Immunoglobulin G (IgG) 
Immunoglobulin G was isolated from crude 
immunoglobulins on DEAE Sephacel colummn. IgG was also 
isolated fay the adsorption method of Stanworth (1960). 
a. Preparation of Crude Immunoclobulins by Precipitating the 
Serum with Saturated Ammonium Sulphate 
To 6.5 ml of fresh serum was added dropwise saturated 
ammonium sulphate allowing each drop to disperse before the 
next was added. When the concentration of ammonium sulphate 
reached about 207. of saturation, the serum had begun to turn 
milky. Most immunoglobulins got precipitated by 35-377. of 
saturation. The reaction was carried out at 4<'C Higher 
concentration of ammonium sulphate did not increase the yield 
of immunoglobulins, but caused increased contamination of 
other proteins, especially transferrin and albumin. The 
suspension was stirred for thirty minutes and then 
centrifuged at 10,000 RPM for 15 min. The pellet thus 
obtained was washed two to three times in 357. saturated 
ammonium sulphate. Repeated washing of the pellet 
considerably reduced contamination with non-immunoglobulin 
proteins and did not lower the yield significantly. Finally 
the precipitate was dissolved in phosphate buffered saline 
(PBS, pH 8.0). Ammonium sulphate was removed by overnight 
dialysis against 500 - 1000 volumes of 0.0175 M Na-phosphate 
buffer, pH 6.8. The dialysis fluid was changed several times 
at intervals of a few hours. 
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b. DEAE Bephacel column chromatography 
Dialysed crude immunoglobulins m 0.0175 M N-^ -
phosphate buffer, pH 6.8 were loaded onto a column of DEAE-
Sephacel (1.5 cm x 20 cm) previously equilibrated with the 
same buffer (0.175 M Na~phosphate, pH 6.8). The column was 
eluted with 0.0175 M Na-phosphate buffer, pH 6.8. Fractions 
of 3.0 ml were collected and momitored for protein content 
at 280 nm, assuming 14 O.D.aaonm = 10 mg IgG/ml (Fig.3 ). 
First peak of the chromatogram was pooled and used as 
purified IgG. A 7.57. SDS-polyacry lamide slab gel 
electrophoresis of the material gave a single band (Fig-4). 
5. Isolation of IgG by DEAE Cellulose Adsorption Method 
Approximately 17 gm of moist DEAE cellulose 
previously washed and equilibrated with 0.01 M Na-phosphate 
buffer containing 0-015 M NaCl, pH 7.5 was mixed with 2.5 ml 
of cold Na~phosphate buffer pH 8.0. Previously dialysed serum 
(2.5 ml) at 4<='C against Na-phosphate buffer, pH 8.0 was added 
dropwise to the exchanger with stirring. The mixture was 
kept at 4^C for 5 hr. Thereafter, 5.0 ml of cold phosphate 
buffer was added and the resulting slurry was centrifuged m 
cold for 15 - 20 min at an speed of 10,000 RPM. The 
supernatant containing IgG was decanted and cleared off 
cellulose by recentrifugation. The homogeniety of isolated 
IgG was checked on 7.57. SDS-polyacrylamide slab gel 
elecrtrophoresis. A single band was observed. 
6. Chromatography of dsDNA on Hydroxyapatite Column 
Three ml of calf thymus DNA (400 JJg/ml ) in 10 mM Na-
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phosphate buffer, pH 7.2 was loaded onto a hydroxyaphatite 
column (1.5 cm K 10 cm) previously washed and equilibrated 
with 10 mM Na-phosphate buffer. After loading, the column 
was washed with 10 mM Na-phosphate buffer. The bound 
material was eluted using linear ionic strength gradient of 
100 mM - 500 mM Na-phosphate buffer, pH 7.2. Three ml 
fractions were collected and monitored for DNA at 260 nm. 
DNA in peak fractions were also estimated with diphenylamine 
reagent. DNA Fractions eluted at 0.26 M Pi were considered as 
dsDNA (Fig. 5). 
7. Preparation of ssDNA 
Single stranded DNA was prepared by heating 
hydroKyapatite purified dsDNA for twenty minutes in boiling 
water followed by immediate chilling of the contents in ice-
NaCl mixture. Stoppered glass tube was used in order to 
prevent the loss of solvent from evaporation. 
8. Polyacrylamide gel electrophoresis 
The purity of the isolated IgG was checked through 
polyacrylamide slab gel electrophoresis under denaturating 
conditions as described fay Laemmli,1970 . 
Stock Solutions 
a. Acrylamide-bisacrylamide (30 : 0.8) 
A stock solution of 307. ^ crylamide containing 0.87. 
bisacrylamide was prepared hy dissolving 30 gram acrylamide 
and 0.8 gram bisacrylamide m a total volume of 100 ml. 
b. Resolving gel buffer, 3 M Tris-HCl (pH 8.8) 
Stock solution of buffer was prepared by dissolving 
36.3 gm Tris in 48.0 ml of 1N HCl. The contents were mixed 
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properly, pH adjusted to 8.8 and the final volume brought to 
100 ml. 
c. Stacking gel buffer, 0-S M Tris-HCl <pH 6.8) 
6.05 gram Tris was dissolved in 40 ml distilled 
water, titrated to pH 6.8 with 1N HCl ( 48 ml), and the 
volume adjusted to 100 ml with distilled water. 
Electrode Buffer 
0.025 M Tris and 0.192 M glycine, pH 8.3 containing 
0.1 percent SDS. 
Sample buffer 
a. Six gram Tris was dissolved in 80 ml distilled water and 
pH adjusted to 6.8 with Phosphoric Acid (H3PO4) The volume 
was made to 100 ml with distilled water. 
b. To 12.5 ml of above sample buffer, was added 1 mg 
bromophenol blue and 12.5 ml glycerol. 
One part of(b) and four part of sample were mixed and boiled 
for five minutes just before electrophoresis. 
Running conditions 
Eighty volts at room temperature for 8 - 1 0 hours. 
RECIPE FOR 7-57. SDS-PAGE 
(35.0 ml total volume) 
Acrylamide-bisacrylamide 
Resolving gel 
107. SDS 
1.57. Ammonium persulphate 
(APS) 
Distilled water 
TEMED 
8.75 ml 
4.375 ml 
350 PL 
1.75 ml 
19.775 ml 
17.5 ML 
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The reagent were mixed in the order shown and poured 
between two glass plates seperated by 1.5 mm thick spacer. 
The gel was allowed to harden at room temperature. The 
samples were loaded,run and stained by Coomassie Brilliant 
Blue R250. 
9. Immunization Schedule 
Rabbits (8-12 months old,weighing 1.0 to 1.5 kg) were 
injected intramuscularly,in hind limbs,for six weeks with 
freshly prepared solutions of 100 Mg NHIgG in Freunds' 
complete and incomplete adjuvant in a total volume of one ml. 
A single animal recieved a total of 600 Mg protein in the 
course of six injections. Ten days after the last dose the 
blood was collected by cardiac puncture and the straw color 
serum was separated four hours after keeping the blood at 
room temperature. The serum was aliquoted in small volumes 
and kept at -20<^ C with O.V/. sodium aside as preservative. 
10.Detection and Quantitation of Antibodies by Various 
Techniques 
Immunized rabbit sera and sera of patients with 
autoimmune disorders were tested for the presence of 
antibodies against NHlgG and nucleic acids by immunodiffusi-
on (ID),counterimmunoelectrophoresis (CIE) and enzyme linked 
immunosorbent assay (ELISA). 
ID was carried out by Ouchterlony double diffusion 
system using glass petri dishes. Six ml of 0.47. molten 
agarose in PBS containing 0.17. sodium azide) was poured onto 
glass petri dishes and allowed to solidify at room 
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temperature. Wells, each 5 mm in diameter and seperated by 8 
mm distance were cut into hardened agarose gel. Serum and 
NHIgG (10 )JL each) were placed in the wells and the 
petridishes were stored in a moist chamber at room 
temperature for 48-72 hours. The gels were washed with 5.0"/. 
Na-citrate -for two hours to remove non specific precipitin 
lines. The result was analyzed visually and recorded-
CIE was carried out according to the procedure 
described by Kurata and Tan (1976) with some modifications. 
Molten agarose (0.6"/.) in 25 mM barbital buffer, pH 8.4 
containing 0.1"/. sodium azide was poured onto 2.5 mm thick 
glass slides (2.5 cm x 7.5 cm) and allowed to harden at room 
temperature. The slides were stored at 4<='C and used within a 
week. The wells, 3 mm in diameter,were cut on the slides at a 
distance of 5 mm between the two opposite wells. Antigen (100 
}Jg NHIgG in 100 JiL) was placed in cathodal well and 
antibodies (immune sera or IgG) in the anodal well. 
Elecrophoresis was performed for 30 minute in 50 mM barbital 
buffer,pH 8.4 with a current of 3-4 mA per slide. The slides 
were treated with Na-citrate as in case of ID to remove 
nonspecific precipitin lines. 
a. Enzyme Linked Immunosorbent Assay (ELISA) 
Buffers and Substrate 
i. Tris buffer saline (TBS), pH 7.4 
10 mM Tris, 150 mM NaCl pH 7.4 containing 0.027. sodium 
azide as preservative. 
ii.Tris buffer saline Tween-20 (TBS-T), pH 7,4 
2.4 gm Tris (20 mM), 8.4 gm sodium chloride, 200 mg 
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polssium chloride and 500 ^L Tween-EO was dissolved in 800 ml 
distilled water, pH adjusted to 7.4 with IN HCl. The volume 
was made to 1000 ml. 
iii.Bicarbonate buffer, pH 9.5 
15 mri sodium carbonate, 35 mM sodium bicarbonate pH 
9.5 containing 0.02 percent sodium aside as preservative, 
iv.Substrate 
500 Mg p-nitrophenyl phosphate/ml in bicarbonate 
buffer. 
Procedure 
Techniques of Aotsuka et al,(1979) with slight 
modifications (Ishaq and Ali,19S3) was used for the detection 
and quantitation of antibodies. 
Polystyrene microtiter plates were incubated with 100 
JJL poly D-lysine solution (50 Jig/ml in water). The plates 
were washed three times with TBS and coated with 100 )JL of 
nucleic acid antigen at a concentration of E.5 )ig/ml in TBS 
for two hours at room temperature followed by overnight 
incubation at 4<=>C. The plates were washed three times with 
TBS-T and saturated by incubation with 100 ML of poly L-
glutamate (50 jJg/ml in TBS) for two hours at room 
temperature. After three wash with TBS-T, the plates could be 
stored at 4'=>C for atleast a week without any significant loss 
in binding capacity. The unoccupied sites were saturated by 
incubation with 100 pL/well of 17. BSA in TBS for six hours at 
room temperature. Antibody (100 pL) to be tested, diluted in 
17. TBS-BSA was added to antigen and control wells. After two 
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hours incubation at room temperature and overnight at 4'='C,the 
plates were washed thrice with TBS-T. Bound antibodies were 
assayed with an appropriate anti-immunoglobulin alkaline 
phsphatase conjugate using p-nitrophenyl phosphate as 
substrate. The absorbance of each well was monitored at 410 
nm on an automatic microplate reader. E'ach sample was coated 
in duplicate. Results were expressed as a mean of Ar,»»t,~ 
11.Inhibition ELISA 
The specificity of ELISA were ascertained by 
inhibition experiments <Ali and Ali,19S6). Varying amounts of 
inhibitors (0-10 jJg/ml ) were mixed with a constant amount of 
antiserum or anti IgG. The mixture was incubated for two 
hours at room temperature and 16-20 hours at 4'^ C. The 
resulting immune complex was coated on wells instead of 
serum. Rest of the steps were as in simple ELISA. 
11.Determination of Hexose Content of IgG 
The neutral hexose content of normal human IgG was 
determined by the method of Dubois et al,(1956). fo one ml of 
protein solution was added 1.0 ml of 5"/. phenol (distilled) 
and mixed thoroughly. Five ml of concentrated sulphuric acid 
was added on the surface of the solution, to produce desired 
mixing. The red orange color developed was read at 490 nm 
against the reagent blank. The hexose content of protein was 
determined by computing the absorbance with that of standard 
curve, drawn with glucose (Fig.6 ). 
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III RESULTS 
1. Production of anti-human IgG in rabbits 
Rabbits immunized with normal human IgG complexed 
with Freunds' complete/incomplete adjuvants were tested for 
the presence of antibodies by counterimmunoelectrophoresis 
(CIE), immunodiffusion (ID) and ELISA. The antibody titer was 
found to be 1:16 by Ouchterlony double diffusion in agarose 
gel. Further, the specificity of antigen-antibody reaction 
was ascertained by immunocrossreactivity of antiserum with 
normal human IgG, normal human serum and serum albumin 
(Fig.7). The results showed reactivity with serum and IgG but 
nonreactivity with serum albumin. ELISA of the immuneserum on 
plate coated with normal human IgG showed a titer of 1:6400 
with no appreciable antigen binding by preimmune serum 
(F i g . 8) . 
2. Detection and Quantitation of SLE Autoantibodies 
The presence of autoantibodies to self antigens 
including nucleic acids (Hahn,1980; Ian,1982) have been 
detected in the sera of SLE patients. The characterization of 
autoantibodies from this laboratory is well documented (Ishag 
and All,1983? Kumar and All,1984; Ishaq and All,1987). For 
the detection and quantitation of naturally occurring 
antibodies in the sera of SLE patients, ELISA utilizing poly 
D-lysine to increase the antigen immobilization on 
polystyrene flat bottom microtiter plates were employed. A 
colorigenic substrate, p-nitrophenyl phosphate was used to 
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Fig.7. Immunocrossreactivity of rabbit anti-
normal human IgG 
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monitor the enzyme activity. 
Normal human sera and sera of patients with systemic 
lupus erythematosus were tested for the presence of anti-DNA 
antibodies by CIE and ID. Both the techniques failed to 
detect precipitating anti-DNA antibodies. Among several SLE 
sera tested by direct ELISA a few showing high titer 
antibodies (>1:1600) were opted for further studies. Normal 
human serum tested at different dilutions did not show 
appreciable binding (Fig.9 ) 
The DEAE Sephacel isolated IgG from both normal human 
and SLE sera, when tested for the presence of anti-DNA 
antibody activity (Fig.10 ) showed different order of 
magnitude of binding. Their immunoglobulins showed antibody 
activity with ssDNA (Fig.11). The binding of normal human IgG 
was of low order. 
In order to check the specificity of the assay, 
inhibition experiments were carried out. Hydroxyapatite 
purified dsDNA was mixed with anti-DNA positive SLE IgG (30 
yg) to give a final inhibitor concentration of 0-10 jJg/ml. 
After incubation for two hours at 4<='C, the resulting complex 
was coated instead of serum. The high degree of specificity 
was evident from the data (Fig.lH ). The inhibition 
experiments with ssDNA and RNA (Fig.13) showed a high degree 
of inhibition with ssDNA. RNA showed about 45"/. inhibition at 
a higher concentration. Fifty percent inhibition of antibody 
activity with both ssDNA and dsDNA was observed at a 
concentration of 1.0 )Jg/ml. 
Because of the diverse nature of SLE IgG (Pisetsky et 
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al, 1985,1987), synthetic homo polymers and alternate 
copolymers were also employed as inhibitors of antibody 
activity. The percent inhibition with poly <dA), poly (dT), 
poly (dG) and poly (dC) is shown in Fiigure 14. Out of these 
homopolymers only poly dC and poly dl were inhibitory. Unlike 
homopolymers, the alternate copolymers poly (dG.dC) poly 
(dG.dC) and poly (dA.dT) poly (dA.dT) were found to be 
effective inhibitors of antibody activity (Fig.15 ). Fifty 
percent inhibition was seen at 0.2 Mg poly (dA.df) poly 
(dA.dT) while 1.5 Mg of poly (dG.dC) poly (dG.dC) was 
required for the same inhibition. The maximum inhibition 
achieved was 80.5 and 90.0 percent respectively (Table 2). 
Glycoprotein Nature of IgG 
IgG gave a positive reaction with phenol-sulphuric 
acid reagent, specific for glycoproteins. Using glucose as 
standard, IgG was found to contain 1.13 percent neutral 
heKose, out of 3.1 percent total sugar content. 
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Table 2 
Competitive inhibition studies data of SLE IgG 
Source of 
Ant ibody 
Inhibitors* Concent rat ii 
507. Inhibit 
(Jig/ml) 
on for 
ion 
P 
I 
er 
nh 
centage 
i bit ion 
IgG nDNA •1.0 76.0 
ssDNA •1.0 80.0 
poly 1 :dA.dT) a 0.2 80.5 
poly 1 
poly 
poly 
poly 
poly 
[dG.dO 
(dT) 
(dC> 
(dG> 
(dA) 
St 1.5 
E.6 
4.6 
90.0 
58.0 
69.5 
0.0 
20.0 
RNA — 45.0 
'Inhibitors were present at a concentration of (0-10) Mg/ml. 
SLE IgG was used at a final concentration of 30 JJg/ml . 
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IV DISCUSSION 
The presence of anti-nucleic acid antibodies in the 
serum of humans and various animals possessing different 
autoimmune traits is of considerable importance, both clinic-
ally and eKperimentally (Stollar,1973,1975; Notman et al, 
1975; Provost,1979; Lerner et al, 1981). Among anti-nucleic 
acid antibodies, the antibodies against native DNA has 
recieved much attention because of its correlation with SLE 
and its period of clinical activity. Generally sera of SLE 
patients contain a multitude of antibody population with 
varying antigenic specifity (Stollar,1975; Gilliam et al, 
1980). There has been considerable interest in defining 
specifities of these antibodies, since guestion has arisen 
whether anti-DNA assays are reliable for diagnosis and monit-
oring disease activity, and whether antibodies with 
particular specificity may be especially significant for pat-
hogenesis and diagnosis. Attempts to define individual speci-
ties are often difficult or indeed impossible in view of the 
vast heterogeniety. Further, assessment of specificities have 
generally relied upon poorly defined complex substrates such 
as calf thymus DNA wherein the dsDNA is always contaminated 
by some single stranded regions and vice-versa. 
The DEAE Sephacel isolated IgG from SLE serum showed 
strong reactivity with nE)NA, ssDNA, RNA and other single and 
double stranded synthetic DNA polymers. This broad range of 
epitope recognition by the antibody support earlier 
observations regarding heterogeniety of SLE serum. However, 
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the major population of IgG recognized deoxyribose phosphate 
backbone or secondary stucture in both native and denatured 
DNA. For fifty percent inhibition in antibody activity the 
amount of both ds- and ssDNA required as inhibitor was 1.0 Mg 
and inhibition was almost to the level of SO"/, with either of 
the polymer. The inhibition in SLE IgG antibody activity with 
buffalo thymus RNA and single stranded synthetic homopolymers 
suggests the simultaneous presence of base specific 
antibodies in polyclonal SLE sera. This also suggests that 
antigenic determinant is restricted to some specific portion 
of the heterocyclic ring and does not encompasses the entire 
base structure. 
Seventy percent inhibition in antibody activity with 
poly (dC) and 58 percent with poly (dT), while only twenty 
percent inhibition with poly (dA) and no inhibition with poly 
(dG) suggests that antigenic determinant does not lie atleast 
in the imidazole ring. Because, if the determinants were in 
the imidazole ring the zero percent inhibition with poly (dG) 
would not be obtained. The common antigenic determinants in 
both cytosine and thymine is carbon 2(C-2) and oxygen EiO-H). 
More inhibition with poly (dC) than poly (dT) could be 
probably due to contribution of epitopes C-4 and N-4 of poly 
dC besides C-2 and 0-2. Carbon 6 (C-6) and nitrogen 6 (N-6) 
of adenine in poly (dA) seems to be responsible for twenty 
percent inhibition in antibody activity as the possibility of 
participation of imidazole ring in antigenicity has already 
been ruled out. The findings are in agreement with Weisbart 
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et al,1983 who reported thai SLE and rheumatoid arthrxtis 
patients possessed antibody activity primarily directed 
toward G and/or C. Moreover, forty five percent inhibition in 
in activity with RNA further substantiate the observatio for 
the presence of base specific antibodies in SLE serum. 
Because of the stuctural difference between backbones of DNA 
and RNA it could be assumed that antigenic determinant in 
case of RNA is neither sugar-phosphate backbone nor 
oligonucleotide sequences but bases. 
The strong reactivity of double stranded form of poly 
(dG.dC)a; and poly (dA.dT)a with SLE IgG further supports the 
presence of backbone or secondary structure specific 
antibodies. The order of reactivity of SLE IgG with various 
DNA conformers was 
Poly (dG.dC)a:> poly (dA.dT)e > ssDNA > nDNA > RNA 
It is concluded that SLE antibodies were polyspecific 
recognising some epitopes on bases as well as secondary 
structure of the DNA and anti-ssDNA antibodies are not 
independent of anti-dsDNA antibodies. 
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